세계의 POC 지질검사 시장 : 성분, 적응증, 최종 사용자별 예측(2025-2030년)

The POC Lipid Testing Market was valued at USD 315.41 million in 2023, expected to reach USD 333.33 million in 2024, and is projected to grow at a CAGR of 6.18%, to USD 480.15 million by 2030.

Point-of-Care (POC) Lipid Testing is an emerging segment within the broader diagnostics landscape, focused on providing immediate lipid profile analysis outside traditional laboratory settings, such as clinics and home environments. This rapid testing paradigm serves the critical need for early detection of conditions like cardiovascular diseases and diabetes, which require continual monitoring of lipid levels. The utility of POC lipid testing lies in its ability to offer swift, reliable results, enabling healthcare providers to make timely decisions and personalize patient care. Rapid urbanization and rising healthcare awareness are propelling demands across varied settings, from clinical laboratories to home healthcare, extending the end-use scope significantly. Key growth influencers include increasing incidences of chronic diseases, technological advancements in portable testing devices, and consumer preference for quick, convenient diagnostics. However, the market faces limitations like regulatory challenges, cost constraints, and issues concerning accuracy that could impact wider adoption. Despite these hurdles, recent advances in nanotechnology and biosensors present fertile ground for innovation, offering opportunities to enhance accuracy and reduce costs, thus expanding market reach. Companies can capture these opportunities by investing in R&D focused on next-generation POC devices and fostering collaborations with healthcare providers to educate patients about the benefits of POC testing. The nature of the market is competitive, with several players striving for market share through diversification and innovation in product lines. As the market evolves, integrating artificial intelligence and data analytics to enhance predictive diagnostics can be key differentiators. In summary, while challenges exist, focusing on technological advancements, regulatory compliance, and strategic partnerships can enable sustained growth in the POC lipid testing market, making it an area ripe for exploration and innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving POC Lipid Testing Market

The POC Lipid Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in prevalence of cardiovascular disease across the globe
  • Rising investment on healthcare by private and public sector
• Market Restraints
  • High cost associated with the production of POC lipid testing products
• Market Opportunities
  • Ongoing innovation in medical industry for developing point of care lipid test products
  • Improving accessibility to healthcare and tests with rise in number of diagnostic centers
• Market Challenges
  • Quality concerns associated with POC lipid testing

Porter's Five Forces: A Strategic Tool for Navigating the POC Lipid Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the POC Lipid Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the POC Lipid Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the POC Lipid Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the POC Lipid Testing Market

A detailed market share analysis in the POC Lipid Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the POC Lipid Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the POC Lipid Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the POC Lipid Testing Market

A strategic analysis of the POC Lipid Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the POC Lipid Testing Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc. by Zoetis Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMerieux SA, Callegari Srl, Chembio Diagnostic Systems, Inc. by BIOSYNEX SA, Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., General Life Biotechnology Co., Ltd., Helena Laboratories Corporation, Menarini Group, Nova Biomedical, Quidel Corporation, SD Biosensor, Inc., Sekisui Medical Co., Ltd., Siemens AG, Sienco, Inc., Sinocare Inc., Thermo Fisher Scientific Inc., Trinity Biotech PLC, VivaChek Biotech (Hangzhou) Co., Ltd., and Werfen, S.A..

Market Segmentation & Coverage

This research report categorizes the POC Lipid Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Instruments and Software.
• Based on Indication, market is studied across Cardiovascular Disease, Hypercholesterolemia, Hyperlipidaemia, and Tangier Disease.
• Based on End-User, market is studied across Diagnostic Centers and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in prevalence of cardiovascular disease across the globe
    • 5.1.1.2. Rising investment on healthcare by private and public sector
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the production of POC lipid testing products
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing innovation in medical industry for developing point of care lipid test products
    • 5.1.3.2. Improving accessibility to healthcare and tests with rise in number of diagnostic centers
  • 5.1.4. Challenges
    • 5.1.4.1. Quality concerns associated with POC lipid testing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. POC Lipid Testing Market, by Component

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Software

7. POC Lipid Testing Market, by Indication

• 7.1. Introduction
• 7.2. Cardiovascular Disease
• 7.3. Hypercholesterolemia
• 7.4. Hyperlipidaemia
• 7.5. Tangier Disease

8. POC Lipid Testing Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostic Centers
• 8.3. Hospitals & Clinics

9. Americas POC Lipid Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific POC Lipid Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa POC Lipid Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abaxis, Inc. by Zoetis Inc.
• 2. Abbott Laboratories
• 3. Bio-Rad Laboratories, Inc.
• 4. bioMerieux SA
• 5. Callegari Srl
• 6. Chembio Diagnostic Systems, Inc. by BIOSYNEX SA
• 7. Danaher Corporation
• 8. EKF Diagnostics Holdings plc
• 9. F. Hoffmann-La Roche Ltd.
• 10. General Life Biotechnology Co., Ltd.
• 11. Helena Laboratories Corporation
• 12. Menarini Group
• 13. Nova Biomedical
• 14. Quidel Corporation
• 15. SD Biosensor, Inc.
• 16. Sekisui Medical Co., Ltd.
• 17. Siemens AG
• 18. Sienco, Inc.
• 19. Sinocare Inc.
• 20. Thermo Fisher Scientific Inc.
• 21. Trinity Biotech PLC
• 22. VivaChek Biotech (Hangzhou) Co., Ltd.
• 23. Werfen, S.A.